UNSPSC 51434918: Candesartan/hydrochlorothiazide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434918 Candesartan/hydrochlorothiazide is a Commodity code that in practice captures state and local procurement of emergency medical and acute-care pharmaceuticals used by fire rescue, emergency medical services, and hospital systems. The recent solicitation activity shows state and local buyers sourcing specific branded or generic medication line items — vials, injections, and single-dose units — with firm pricing, expiration-date guarantees (typically nine months or more from acceptance), and rapid delivery windows (ten calendar days or less). Issuing bodies include municipal purchasing departments acting on behalf of fire rescue and EMS divisions, indicating that the code serves primarily municipal emergency services rather than hospital networks or retail pharmacy channels.

The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with an estimated contract value of $40,000.00 and a response deadline of April 8, 2026. The solicitation named four specific medication line items — Labetalol HCI, Epinephrine, Adenosine, and Diltiazem — in defined unit quantities and concentrations, underscoring that this code encompasses procurement of individual active pharmaceutical ingredients and formulations rather than multi-drug bundles or pharmacy management services. The contract included a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount, capped at $10,000. No other recent state and local opportunities under this code appear in the source.